Aim & Scope
Medicine in Omics is a peer-reviewed open access journal. The journal publishes human health related original omics research, including genomics, proteomics, epigenomics metabolomics, lipidomics, peptidomics, metagenomics, microbiomics, pharmacogenomics, toxicogenomics etc., with the focus on disease etiology, prevention, diagnosis, treatment and therapy, prognosis and monitoring. Medicine in Omics is an Official Journal of Peking University Health Science Center. [1]
2024
S Muthukrishnan , A Ravi , S Ajay , ... , A Kaliyaperumal
Medicine in Omics , 2024 , p 100032.
0
30
The Integration of Omics: A Promising Approach to Personalized Tuberculosis Treatment
P Guha , S Dutta , K Murti , ... , S Dhingra
Medicine in Omics , 2024 , p 100033.
1
87
IMMUNOLOGICAL STORM AND MULTIPLE ORGAN DAMAGE BY COVID-19
A Yaser Arafath , S Aifa Fathima , A Prabhakaran , ... , J Selvin
Medicine in Omics , 2024 , p 100034.
0
160
D Kumar Jha , N Yashvardhini , A Kumar , ... , K Sayrav
Medicine in Omics , 2024 , p 100036.
0
0
Early-stage biomarkers identification by integrated genomic analysis in Hepatocellular carcinoma
Medicine in Omics , 2024 , p 100037.
0
0
Systems medicine framework for repurposable drug combinations for COVID-19 comorbidities
S Saranya , L Thamanna , P Chellapandi
Medicine in Omics , 2024 , p 100038.
1
127
The omics technologies and liquid biopsies: Advantages, limitations, applications
D Magro , M Venezia , C Rita Balistreri
Medicine in Omics , 2024 , p 100039.
1
149